April 1, 2024
NIH cancer physician-scientist Christopher Hourigan joins Virginia Tech to lead research in Washington, D.C.
A globally recognized physician-scientist who studies and treats blood cancer is joining Virginia Tech to lead cancer research in Washington,…
March 31, 2024
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet
Amsterdam, March 15, 2024 – The government of the Netherlands has allocated €200 million from the country’s National Growth Fund for…
March 28, 2024
CNBC – Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a…
March 21, 2024
WBJ: Germantown Precigen Inc. biotech expands manufacturing capacity, headcount ahead of potential product launch
Germantown’s Precigen Inc., a clinical-stage biotech developing gene and cell therapies for cancers and other diseases, is taking steps to…
March 21, 2024
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities AstraZeneca has entered into…